SAFETY AND IMMUNOGENICITY IN CHILDREN AND ADULTS FROM ENDEMIC COUNTRIES AND ADULTS FROM NONENDEMIC COUNTRIES OF A TETRAVALENT, LIVE ATTENUATED DENGUE VACCINE

被引：0
|
作者：
Bouckenooghe, Alain [1 ]
Capeding, Maria R. [2 ]
Morrison, Dennis N. [3 ]
Poo, Jorge L. [4 ]
Lang, Jean [5 ]
Chambonneau, Laurent [5 ]
Forrat, Remi [5 ]
机构：
[1] Sanofi Pasteur, Swiftwater, PA USA
[2] Res Inst Trop Med, Muntinlupa, Philippines
[3] Biokinet Clin Applicat, Springfield, MO USA
[4] Hosp Med Sur, Mexico City, DF, Mexico
[5] Sanofi Pasteur, Marcy Letoile, France
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2008年 / 79卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
386
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [21] A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults
    Gunale, Bhagwat
    Farinola, Nicholas
    Yeolekar, Leena
    Shrivastava, Shubham
    Girgis, Hanna
    Poonawalla, Cyrus S.
    Dhere, Rajeev M.
    Arankalle, Vidya
    Mishra, Akhilesh Chandra
    Mehla, Rajeev
    Kulkarni, Prasad S.
    VACCINE, 2023, 41 (38) : 5614 - 5621
  • [22] Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study
    Sirivichayakul, Chukiat
    Barranco-Santana, Elizabeth A.
    Esquilin-Rivera, Ines
    Oh, Helen M. L.
    Raanan, Marsha
    Sariol, Carlos A.
    Shek, Lynette P.
    Simasathien, Sriluck
    Smith, Mary Kathryn
    Dario Velez, Ivan
    Wallace, Derek
    Gordon, Gilad S.
    Stinchcomb, Dan T.
    JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (10): : 1562 - 1572
  • [23] Biodistribution and safety of a live attenuated tetravalent dengue vaccine in the cynomolgus monkey
    Ravel, Guillaume
    Mantel, Nathalie
    Silvano, Jeremy
    Rogue, Alexandra
    Guy, Bruno
    Jackson, Nicholas
    Burdin, Nicolas
    VACCINE, 2017, 35 (43) : 5918 - 5923
  • [24] Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial
    George, Sarah L.
    Wong, Mimi A.
    Dube, Tina J. T.
    Boroughs, Karen L.
    Stovall, Janae L.
    Luy, Betty E.
    Haller, Aurelia A.
    Osorio, Jorge E.
    Eggemeyer, Linda M.
    Irby-Moore, Sharon
    Frey, Sharon E.
    Huang, Claire Y. -H.
    Stinchcomb, Dan T.
    JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (07): : 1032 - 1041
  • [25] Safety and infectivity of tetravalent Chimeric live attenuated dengue vaccine in different age populations in endemic and non-endemic areas
    Morrison, Dennis
    Capeding, Maria Rosario
    Poo, Jorge Luis
    Forrat, Remi
    Zambrano, Betzana
    Wartel-Tram, Anh
    Dumas, Rafaele
    Lang, Jean
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (05): : 99 - 99
  • [26] Safety and Immunogenicity of a Rederived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults Living in Thailand: A Randomized Trial
    Watanaveeradej, Veerachai
    Gibbons, Robert V.
    Simasathien, Sriluck
    Nisalak, Ananda
    Jarman, Richard G.
    Kerdpanich, Angkool
    Tournay, Elodie
    De La Barrerra, Rafael
    Dessy, Francis
    Toussaint, Jean-Francois
    Eckels, Kenneth H.
    Thomas, Stephen J.
    Innis, Bruce L.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2014, 91 (01): : 119 - 128
  • [27] Live attenuated influenza vaccine use and safety in children and adults with asthma
    Duffy, Jonathan
    Lewis, Melissa
    Harrington, Theresa
    Baxter, Roger
    Belongia, Edward A.
    Jackson, Lisa A.
    Jacobsen, Steven J.
    Lee, Grace M.
    Naleway, Allison L.
    Nordin, James
    Daley, Matthew F.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 118 (04) : 439 - 444
  • [28] Long-Term Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine and Evaluation of a Booster Dose Administered to Healthy Thai Children
    Watanaveeradej, Veerachai
    Simasathien, Sriluck
    Mammen, Mammen P., Jr.
    Nisalak, Ananda
    Tournay, Elodie
    Kerdpanich, Phirangkul
    Samakoses, Rudiwilai
    Putnak, Robert J.
    Gibbons, Robert V.
    Yoon, In-Kyu
    Jarman, Richard G.
    De La Barrera, Rafael
    Moris, Philippe
    Eckels, Kenneth H.
    Thomas, Stephen J.
    Innis, Bruce L.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2016, 94 (06): : 1348 - 1358
  • [29] Clinical efficacy, Safety, and immunogenicity of a Live Attenuated Tetravalent Dengue vaccine (CYD-TDv) in Children: A Systematic Review with Meta-analysis
    Malisheni, Moffat
    Khaiboullina, Svetlana F.
    Rizvanov, Albert A.
    Takah, Noah
    Murewanhema, Grant
    Bates, Matthew
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [30] Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study
    Osorio, Jorge E.
    Velez, Ivan D.
    Thomson, Cynthia
    Lopez, Liliana
    Jimenez, Alejandra
    Haller, Aurelia A.
    Silengo, Shawn
    Scott, Jaclyn
    Boroughs, Karen L.
    Stovall, Janae L.
    Luy, Betty E.
    Arguello, John
    Beatty, Mark E.
    Santangelo, Joseph
    Gordon, Gilad S.
    Huang, Claire Y-H
    Stinchcomb, Dan T.
    LANCET INFECTIOUS DISEASES, 2014, 14 (09): : 830 - 838
12345